El.En.

Investor Presentation • Jun 21, 2016

COMPANY PRESENTATION

June 21th, 2016

Disclaimer

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Summary

• 1.LASERS AND LASER APPLICATIONS
• 2.THE GLOBAL LASER MARKET
• 3.EL.EN. GROUP
• 4.Q1 - ²⁰¹⁶ FINANCIAL RESULTS
• 5.²⁰¹⁶ GUIDANCE

Lasers and Laser Applications

LASER

Light Amplification by Stimulated Emission of Radiation

MEDICALLASER Systems

INDUSTRIALLASER Systems

Surgical Laser systems

Aesthetic Laser systems

Industrial lasers applications

The Global Laser Market

The MEDICAL Laser Market

\$ l b l k f d l l b d h h ( l l ) i i i G 2 0 1 9 t t o a m a r e o r m e c a a s e r s y e n u s e r o u g m o n s ,
2 0 1 3	2 0 1 4	2 0 1 9	C A G % R
			2 0 1 4 2 0 1 9 -
7 5 8	8 1 3	1 2 1 9	% 8 4 ,
8 9 5	0 2 1 4	2 0 9 7	% 1 5 4 ,
2 0 9	2 4 4	6 2 3	2 0 % 7 ,
9 9	1 1 5	2 4 7	1 6 % 5 ,
1 9 6 1	2 1 9 5	4 1 8 5	1 3 8 % ,

Global market for medical lasers by region, through 2019 (\$ millions)

k M S t t a r e e g m e n	2 0 1 3	2 0 1 4	2 0 1 9	% C A G R
				2 0 1 4 2 0 1 9 -
d d U S C a n a n a a	9 0 2	1 0 0 8	1 8 7 0	1 3 2 % ,
E u r o p e	5 7 9	6 4 7	1 2 0 8	% 1 3 3 ,
f i i i A P s a a c c	3 5 2	3 9 9	8 4 9	% 1 6 3 ,
h O t e r	2 8 1	1 4 1	2 8 5	2 8 % 1 ,
l T t o a	9 6 1 1	2 9 1 5	8 4 1 5	3 8 % 1 ,

The INDUSTRIAL Laser Market

Global market and forecast for high power laser systems by application (by value)

l B V a e y u	l b l G M o a a	k ( l i E U R M t r e	( ) C A G R %
	2 0 1 3	2 0 1 6	2 0 2 0	2 0 1 3 2 0 1 6 -	2 0 1 6 2 0 2 0 -
C i t t n u g	2 4 0 8	3 0 1 4	3 9 6 5	7 8 ,	7 1 ,
l d d i i W B e n g a n r a n g z	1 2 4 9	1 6 0 5	2 2 3 1	8 7 ,	8 6 ,
f d h S O t t t t u r a c e r e a m e n a n e r	5 0	6 3	8 6	8 3 ,	8 1 ,
l T t o a	3 7 0 7	4 6 8 2	6 2 8 2	8 1 ,	7 6 ,

El.En. Group

Group Overview

High –Tech laser photonics Group

Develops, manufactures and distributes laser sources and laser systems for medical and industrial applications

Know-how based on 35 years stratification of multidisciplinary experience

FY 2015: Consolidated Revenues of €218 mln, up 21% YoY Q1 2016: Consolidated Revenues of €55 mln, up 14% YoY

⁹⁸⁰ employees

Global positioning

Strategic Strengths

Multidisciplinary and multifacility R&D activity: sources, systems, applications

Industrial

Combine High tech laser source development with flexible production facilities in high growth areas

Medical

Technological and clinical innovation improving performance andbroadening the application scope of our laser systems

• Maximize market penetration by multi brand approach
• Open new market segments by developing innovative applications
• Leverage worldwide distribution with multi brand approach

Cynosure

IRR= 32,50%Capital Gain = €92 mln

Consolidated Revenuesand EBIT

R&D Activity

Clinical trials and validations of new therapeutic laser treatments and research on new applications of laser- tissue interaction

Broadening Mona Lisa Touch Clinical studiesNew Pico second laser platform Clinical studies on cutaneous ulcers Painless laser hair removalPatents developmentIncreased power of RF laser sourcesInnovative applications for mid power laser systems

Q1 -2016 Financial Results

Q1 2016 ConsolidatedP&L

Euro/000RevenuesGross marginEBITDAPretax Income

31/03/15 31/03/16 Var.%unaudited unaudited 48.511 100,0% 55.231 100,0% 13,9% 22.242 45,8% 25.400 46,0% 14,2% 5.301 10,9% 7.669 13,9% 44,7% EBIT 4.456 9,2% 6.721 12,2% 50,8% 6.305 13,0%5.813 10,5% -7,8%

Net financial position and CapexEuro '000 31/12/15 31/03/16 30/04/16 (*) Net financial position : 29.815 27.560 67.410 Financial invest. m/l term: 10.64310.701 10.701

(*) including \$45,1 mln of Cyno's shares sale

2016 Guidance

2016 Guidance

Sales 2016 = Sales 2015 +5% -> €229 mln

EBIT 2016 = EBIT 2015 -> €22mln

El.En. SPA

Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: finance@elen.it

POLYTEMS HIR SRL

Bianca FERSINI MASTELLONI Financial CommunicationTel. +39 06-6797849 / +39 06-69923324E-mail: b.fersini@polytemshir.it

POLYTEMS HIR SRL

Silvia MARONGIUPress officeTel. +39 06-6797849 / +39 06-69923324E-mail: s.marongiu@polytemshir.it